AEE · 10-Q · 2026Q3 · Full report
Equity Capital Raise
AMEREN CORP · 2026-11-06 · Importance 89 · Surprise 82 · In source text
Ameren increased its ATM program availability by $2 billion in August 2026, bringing the total program size to $5 billion; approximately $2 billion remained available at September 30, 2026. No shares were issued under the ATM program in the first nine months of 2026, but Ameren had forward sale agreements for 19.4 million shares at September 30 and entered into agreements for an additional 2.1 million shares in October 2026. Ameren expects to settle 6.4 million shares in 2026 and use the remaining 15.1 million shares to fund equity needs beyond 2026. The estimated equity financing plan is approximately $5 billion for 2027–2031, including ATM forward sales, DRPlus, and employee benefit plan issuances.
Key facts
- Ameren estimates its equity financing plan at approximately $5 billion from 2027 to 2031, including forward sale agreements, DRPlus, and employee benefit plans.
- Ameren increased the common stock available for sale under its ATM program by $2 billion in August 2026, to a total of $5 billion.
- Ameren estimates its equity financing plan at approximately $5 billion from 2027 to 2031, with issuances concentrated primarily near year-end 2027 and year-end 2028.
- Ameren had approximately $2 billion of common stock remaining available for sale under its ATM program as of September 30, 2026.
- Ameren increased the common stock available under its ATM program by $2 billion in August 2026, bringing the total to $5 billion.
- Ameren expects to settle 6.4 million forward-sale shares in 2026 and use the remaining 15.1 million shares to fund part of its equity needs beyond 2026.
- Ameren entered into ATM-program forward sale agreements for 2.1 million common shares in October 2026.
- As of September 30, 2026, Ameren had forward sale agreements covering 19.4 million common shares; in October 2026 it entered into additional ATM forward sale agreements for 2.1 million shares.
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | committed | +8.1% | Ameren estimates its equity financing plan at approximately $5 billion from 2027 to 2031, with issuances concentrated primarily near… |
| cash | positive | committed | — | Ameren expects to settle 6.4 million forward-sale shares in 2026 and use the remaining 15.1 million shares to fund part of its equity… |
| cash | positive | committed | — | Ameren expects to settle 6.4 million forward-sale shares in 2026 and use the remaining 15.1 million shares to fund part of its equity… |